Arterial smooth muscle cells dysfunction in hyperglycaemia and hyperglycaemia associated with hyperlipidaemia: From causes to effects

Archives of Physiology and Biochemistry

Volumn 114, Issue 2, 2008, Pages 150-160

  Popov, Doina ^a   Constantinescu, Elena ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Growth; Human aortic smooth muscle cells; Phenotypic modulation; Proliferation; Signalling molecules

Indexed keywords

MESOCRICETUS AURATUS;

EID: 45949095252     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802033990     Document Type: Review

References (72)

1. Abedin M, Tintut Y, Demer LL. 2004. Vascular calcification. Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24:1161-70.
2. Banes AKL, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D, Marrero MB. 2005. Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 288:C805-12.
3. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez J-C, Chaponnier C, Gabbiani G, Bochaton-Piallat M-L. 2007. Intimal smoothmuscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 100:1055-62.
4. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-20.
5. Campbell G, Campbell J. 1990. The phenotypes of smooth muscle expressed in human atheroma. Ann NY Acad Sci 598:143-58.
6. Campbell M, Trimble ER. 2005. Modification of PI3K and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbII. Circ Res 96:197-206.
7. Chen NX, Duan D, O'Neill KD, Moe Sharon M. 2006. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrology Dialysis Transplantation 21:3435-42.
8. Clemmons DR, Maile LA, Ling Y, Yarber J, Busby WH. 2007. Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress. Growth Horm IGF Res 17:265-70.
9. Costache G, Popov D, Georgescu A, Simionescu M. 1999. Functional-structural alterations of the resistance arteries in experimental hyperlipemia or hyperglycemia. Proc Rom Acad Series B 1:31-7.
10. Costache G, Popov D, Georgescu A, Cenuse M, Jinga VV, Simionescu M. 2000. The effects of simultaneous hyperlipemia-hyperglycemia on the mesenteric resistance arteries, myocardium and kidney glomeruli. J Submicrosc Cytol Pathol 32:48-54.
11. Damirin A, Tomura H, Komachi M, Liu J-P, Mogi C, Tobo M, Wang J-Q, Kimura T, Kuwabara A, Yamazaki Y, Ohta H, Im D-S, Sato K, Okajima F. 2007. Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 292:H2513-22.
12. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-72.
13. 2+ channels. Fundamental and Clinical Pharmacology 15:1-8.
14. Gerthoffer WT. 2007. Mechanisms of vascular smooth muscle cell migration. Circ Res 100:607-21.
15. Gutterman DD, Miura H, Liu Y. 2005. Redox modulation of vascular tone: Focus on potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 25:671-8.
16. He R, Qu A-J, Mao J-M, Wang X, Sun W. 2007. Synergistic proliferation induced by insulin and glycated serum albumin in rat vascular smooth muscle cells. Sheng Li Xue Bao 59:1-7.
17. Henry RM, Kostense PJ, Spijkerman AM, Dekke JM, Nijpels G, Heine RJ, Kamp O, Westenhorf N, Bouter LM, Stehouwer CD. 2003. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107:2089-95.
18. House SJ, Ginnan RG, Armstrong SE, Singer HA. 2007. Calcium/ calmodulin-dependent protein kinase II-δ isoform regulation of vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 292:C2276-87.
19. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL. 1999. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103:185-95.
20. Jin L, Kern MJ, Otey CA, Wamhoff BR, Somlyo AV. 2007. Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ Res 100:817-25.
21. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. 2000. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-17.
22. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. 2007. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 100:769-81.
23. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O'Brien KD. 2006. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation 113:2113-19.
24. Ketteler M, Schlieper G, Floege J. 2006. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 47:1027-34.
25. Kiyan J, Kusch A, Tkachuk S, Kramer J, Haller H, Dietz R, Smith G, Dumler I. 2007. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor. Atherosclerosis 195:254-61.
26. Koka V, Wang W, Huang XR, Kim-Mitsuyama S, Truong LD, Lan HY. 2006. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation 113:1353-60.
27. 2+, calmodulin, and cyclins in vascular smooth muscle cell cycle. Circ Res 98:1240-43.
28. Laird DF, Mucalo MR, Yokogawa Y. 2006. Growth of calcium hydroxyapatite (Ca-HAp) on cholesterol and cholestanol crystals from a simulated body fluid: A possible insight into the pathological calcifications associated with atherosclerosis. J Colloid Interface Sci 295:348-63.
29. Liu X, Luo F, Pan K, Wu W, Chen H. 2007. High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells. BMC Cell Biol 8:1.
30. Madamanchi NR, Vendrov A, Runge MS. 2005. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29-38.
31. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR. 2007. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology 148:2435-43.
32. 2+-activated potassium β1 channel subunit in retinal arteriolar smooth muscle. Circulation Research 100:703-11.
33. Naik JS, Xiang L, Hester RL. 2006. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290:R154-61.
34. Nakazawa T, Chiba T, Kaneko E, Yui K, Yoshida M, Shimokado K. 2005. Insulin signalling in arteries prevents smooth muscle apoptosis. Arterioscler Thromb Vasc Biol 25:760-765.
35. Nigro J, Osman N, Dart AM, Little PJ. 2006. Insulin resistance and atherosclerosis. Endocr Rev 27:242-59.
36. Nilsson J, Nilsson LM, Chen Y-W, Molkentin JD, Erlingeand D, Gomez MF. 2006. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26:794-800.
37. Nishikawa T, Du Edelstein DXL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-90.
38. Popov D, Constantinescu E, Shepherd PR. 2004. High glucose-induced alterations in human aortic smooth muscle cells: phenotypic changes and signal transduction mediators. Proc Rom Acad Series B 6:47-51.
39. Popov D, Costache G, Georgescu A, Enache M. 2002. Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster. Cell and Tissue Research 308:109-20.
40. Radu DL, Georgescu A, Stavaru C, Carale A, Popov D. 2004. Double transgenic mice with Type 1 diabetes mellitus develop somatic, metabolic and vascular disorders. J Cellular and Molecular Medicine 8:439-58.
41. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK. 2004. Activation of nuclear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53:2910-20.
42. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK. 2005. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 54:818-29.
43. Ramana KV, Tammali R, Reddy ABM, Bhatnagar A, Srivastava SK. 2007. Aldose reductase-regulated tumour necrosis factor-a production is essential for high glucose-induced vascular smooth muscle cell growth. Endocrinology 148:4371-84.
44. Rask-Madsen C, King GL. 2005. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 25:487-96.
45. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-DechentW,Weissberg PL, Shanahan CM. 2004. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calciumand phosphate concentrations: a potentialmechanismfor accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-67.
46. Rius J, Martinez-Gonzalez J, Crespo J, Badimon L. 2004. Involvement of neuron-derived orphan receptor-1 (NOR-1) in LDL-induced mitogenic stimulus in vascular smooth muscle cells: role of CREB. Arterioscler Thromb Vasc Biol 24:697-702.
47. Rodriguez C, Raposo B, Martinez-Gonzalez J, Llorente-Cortes V, Vilahur G, Badimon L. 2003. Modulation of ERG25 expression by LDL in vascular cells. Cardiovasc Res 58:178-85.
48. Rodríguez-Lee M, Östergren-Lundén G, Wallin B, Moses J, Bondjers G, Camejo G. 2006. Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein. Arterioscler Thromb Vasc Biol 26:130-35.
49. Rong JX, Shapiro M, Trogan E, Fisher Edward A. 2003. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading, Proc Natl Acad Sci USA 100:13531-6.
50. Ruef J, Liu SQ, Bode C, Tocchi M, Srivastava S, Runge MS, Bhatnagar A. 2000. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler Thromb Vasc Biol 20:1745-52.
51. Sakuma H, Yamamoto M, Okumura M, Kojima T, Maruyama T, Yasuda K. 2001. High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1. Am J Physiol Cell Physiol 283:C422-8.
52. San Martín A, Du P, Dikalova A, Lassègue B, Aleman M, Góngora MC, Brown K, Joseph G, Harrison DG, Taylor WR, Jo H, Griendling KK. 2007. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol 292:H2073-82.
53. Seye CI, Kong Q, Erb L, Garrad RC, Krugh B, Wang M, Turner JT, Sturek M, Gonzalez FA, Weisman GA. 2002. Functional P2Y2 nucleotide receptors mediate uridine 50-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106:2720-26.
54. Shao J-S, Cai J, Towler DA. 2006. Molecular mechanisms of vascular calcification. Lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26:1423-30.
55. Shaw S, Schmidt AM, Banes AK, Wang XD, Stern DM, Marrero MB. 2003a. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 52:2381-8.
56. Shaw S, Wang XD, Redd H, Alexander GD, Isales CM, Marrero MB. 2003b. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem. 278:30634-41.
57. Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, Vulpanovici A, Stancu C, Stern D, Simionescu N. 1996. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model: the hyperlipemic hyperglycemic hamster. Am J Pathol 148:997-1014.
58. Srivastava S, Ramana KV, Tammali R, Srivastava SK, Bhatnagar A. 2006. Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes 55:901-10.
59. Srivastava SK, Ramana KV, Bhatnagar A. 2005. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine Reviews 26:380-92.
60. Taylor AM, Li F, Thimmalapura P, Gerrity RG, Sarembock IJ, Forrest S, Rutherford S, McNamara CA. 2006. Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3. J Vasc Res 43:123-30.
61. Tesfamariam B, Brown ML, Cohen RA. 1991. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-8.
62. Thyberg J, Blomgren K, Hedin U, Dryjski M. 1995. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study. Cell Tissue Res 281:421-33.
63. Totary-Jain H, Naveh-Many T, Riahi Y, Kaiser N, Eckel J, Sasson S. 2005. Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ Res 97:1001-8.
64. Towler DA, Shao J-S, Cheng S-L, Pingsterhaus JM, Loewy A.P. 2006. Osteogenic regulation of vascular calcification. Ann NY Acad Sci 1068:327-33.
65. Wada Y, Sugiyama A, Yamamoto T, Naito M, Noguchi N, Yokoyama S, Tsujita M, Kawabe Y, Kobayashi M, Izumi A, Kohro T, Tanaka T, Taniguchi H, Koyama H, Hirano K-I, Yamashita S, Matsuzawa Y, Niki E, Hamakubo T, Kodama T. 2002. Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Arterioscler Thromb Vasc Biol 22:1712-19.
66. Werstuck GH, Khan MI, Femia G, Kim AJ, Tedesco V, Trigatti B, Shi Y. 2006. Glucosamine-Induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes 55:93-101.
67. You B, Ren A, Yan G, Sun J. 2007. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia. Diabetes 56:1445-53.
68. Zhang K, Shen X, Wu J, Sakaki K, Saunders T, Rutkowski DT, Back SH, Kaufman RJ. 2006. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124:587-99.
69. Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ. 2003. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 107:2238-43.
70. Zhu Y, Bujo H, Yamazaki H, Hirayama S, Kanaki T, Takahashi K, Shibasaki M, Schneider WJ, Saito Y. 2002. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation 105:1830-36.
71. Zhu Y, Bujo H, Yamazaki H, Ohwaki K, Jiang M, Hirayama S, Kanaki T, Shibasaki M, Takahashi K, Schneider WJ, Saito Y. 2004. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration. Circ Res 94:752-8.
72. Zieman SJ, Melenovsky V, Kass DA. 2005. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25:932-43.